$GBT: Global Blood Therapeutics Prices a $150.0 Million Common Stock …

Date: Friday, December 7th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: 07, 2018 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a clinical-stage biopharmaceutical company determined to discover, …

Full article address: https://www.benzinga.com/pressreleases/18/12/g12815417/global-blood-therapeutics-prices-a-150-0-million-common-stock-public-o

Related News:

$GBT: How Global Blood Therapeutics Is Capitalizing on Its Sickle Cell …

$GBT: Global Blood prices stock offering; shares down 6% premarket

$GBT: Global Blood Therapeutics Delivers The Good News; What Is The …

$GBT: Global Blood launches $150M stock offering; shares down 4% after …

$GBT: Global Blood Therapeutics Announces Proposed Public Offering of …

$GBT: GBT Announces New Employment Inducement Grants

$GBT: Global Blood Therapeutics Options Pop on FDA Buzz

$GBT $ATOS $BHVN: Healthcare and Industrial goods dominate midday movers

$GBT: Global Blood’s Sickle Cell Disease Drug Snags Accelerated FDA …

$GBT: Global Blood Therapeutics Wins Big With FDA Approval

$GBT: FDA accepts GBT’s proposal for accelerated approval pathway for …

Latest News:

$CVNA $ALNY: Here is What Hedge Funds Think About Carvana Co. (CVNA)

$CF $MRVL $TRGP: Hedge Funds Are Buying CF Industries Holdings, Inc. (CF)

$CL $CME: Here is What Hedge Funds Think About Colgate-Palmolive …

$EXC: Exelon Corporation (EXC)Hedge Funds Are Snapping Up

$CCK $COLM: Should You Buy Crown Holdings, Inc. (CCK)?

$ACN: Pierre Fabre Turns to Accenture to Digitize Corporate and …

$VG: NewVoiceMedia Wins 2018 Contact Center Technology Award …

$WMT: Automation revolution… Walmart testing ‘Flippy’

$EXPR $HAFC: Hedge Funds Are Buying Express, Inc. (EXPR)

$BYD $LITE: Is Boyd Gaming Corporation (BYD) Going to Burn These Hedge …

$FRAN $DSW: Earnings Scheduled For December 11, 2018